Combined Study of Cytogenetics and Fluorescence in Situ Hybridization (FISH) Analysis in Childhood Acute Lymphoblastic Leukemia (ALL) in a Tertiary Cancer Centre in South India

  • Mazloumi, Seyed Hashem Mir (Department of Pathology, Kidwai Memorial Institute of Oncology) ;
  • Madhumathi, D.S. (Department of Pathology, Kidwai Memorial Institute of Oncology) ;
  • Appaji, L. (Pediatric Oncology Department, Kidwai Memorial Institute of Oncology) ;
  • Prasannakumari, Prasannakumari (Department of Pathology, Kidwai Memorial Institute of Oncology)
  • Published : 2012.08.31


FISH is one of the most sensitive molecular methods to detect genetic abnormalities with DNA probes. When cytogenetic studies are normal or insufficient, FISH may detect cryptic rearrangements, rare or slowly proliferative abnormal populations in non-mitotic cells. We cytogenetically evaluated 70 childhood ALL - 67.1% were found to have an abnormal karyotype. The 23 patients (32.9%) with a normal karyotype were analyzed by FISH applying two probes; TEL/AML1 and MYB which detect cryptic rearrangements of t(12;21)(p13;q22) and deletion of (6q) respectively, associated with a good prognosis. Out of 23 patients, one was positive for t(12;21)(p13;q22) (4.3%). None of our patients were positive for MYB del(6q). Two patients showed an extra signal for MYB on chromosomes other than 6 (8.6 %) indicating amplification or duplication. Findings were compared with the available literature. Our study clearly indicated the integrated FISH screening method to increase the abnormality detection rate in a narrow range. FISH is less useful for diagnostic study of patients with suspected del(6q) but it helps in detecting known cryptic rearrangements as well as identification of new abnormalities(translocation , duplication and amplification) at the gene level.


  1. Hee Yeon Woo, Dae Won Kim, Hyoson Park, et al (2005). Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. J Korean Med Sci, 20, 36-41.
  2. Riesch M, Niggli FK, Leibundgut K, Caflisch U, Betts DR (2001). Loss of X chromosome in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet, 125, 27-9.
  3. Sandoval C, Mayer SP, Giamelli J, et al (2000). Cytogenetic abnormalities during clinical, immunophenotypic, and molecular remission in pediatric acute lymphoblastic leukemia. Cancer Genet Cytogenet, 118, 9-13.
  4. Brigitta Swolin, Sting Rodjer, ONE AUTHOR, et al (2000). Cytogenetic studies in patients with mastocytosis. Cancer Genet Cytogenet, 118, 9-13.
  5. Chai YH, Lu H, Li JQ, et al (2007). Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia. Zhonghua Er Ke Za Zhi, 9, 684-6.
  6. Jamil A, Theil KS, Kahwash S, Ruymann FB, Klopfenstein KJ (2000). TEL/AML-1 fusion gene. its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet, 122, 73-8.
  7. T S Sundarashan, D S Madhumathi, L Appaji (2002). Del(2) (P23) as a sole abnormality in a case of acute myeloid leukemia. Cancer Genet Cytogenet, 122, 73-8.
  8. Lisa G Shaffer, Marilyn L, Slovak, Lynda J Campbell (2009). ISCN 2009: An International System for Human Cytogenetic Nomenclature. Cytogenetic and Genome Res, ?, 1-138.
  9. Settin A, Al Haggar M, Al Dosoky T, et al (2007). Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia. Indian J Pediatr, 74, 255-63.
  10. Yehuda-Gafni O, Cividalli G, Abrahmov A, et al (2002). Fluorescence in situ hybridization analysis of the cryptic t(12;21) (p13;q22) in childhood B-lineage acute lymphoblastic leukemia. Cancer Genet Cytogenet, 132, 61-4.
  11. Park KU, She CJ, Shin HY, et al (2001). Low incidence of TEL/ AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization. Cancer Genet Cytogenet, 126, 73-7.
  12. Borowitz M J, Chan J K C (2008). WHO classification of tumors of Haematopoietic and Lymphoid tissues." Int Agency Res Cancer, 9, 173-4.

Cited by

  1. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia vol.12, pp.3, 2014,
  2. Molecular Genetic Studies on 167 Pediatric ALL Patients from Different Areas of Pakistan Confirm a Low Frequency of the Favorable Prognosis Fusion Oncogene TEL-AML1 (t 12; 21) in Underdeveloped Countries of the Region vol.15, pp.8, 2014,
  3. Chromosomal Abnormalities in Pakistani Children with Acute Lymphoblastic Leukemia vol.15, pp.9, 2014,
  4. Geographic/ethnic variability of chromosomal and molecular abnormalities in leukemia vol.15, pp.9, 2015,
  5. Cytogenetic Profile of De Novo B lineage Acute Lymphoblastic Leukemia: Determination of Frequency, Distribution Pattern and Identification of Rare and Novel Chromosomal Aberrations in Indian Patients vol.16, pp.16, 2015,
  6. Importance of FISH combined with Morphology, Immunophenotype and Cytogenetic Analysis of Childhood/Adult Acute Lymphoblastic Leukemia in Omani Patients vol.16, pp.16, 2015,
  7. Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission vol.16, pp.17, 2015,
  8. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing vol.5, pp.2, 2015,
  9. Multiplex RT-PCR Assay for Detection of Common Fusion Transcripts in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Cases vol.17, pp.2, 2016,